Treatment of the Addicted or Dependent Patient in the Family Practice Setting

Similar documents
Medication-Assisted Treatment. What Is It and Why Do We Use It?

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

How many days does hydrocodone stay in your system

Beyond Birth: A Comprehensive Recovery Center serving parenting women

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016

Medication Assisted Treatment

Treating Opioid Addiction

Talking with your doctor

Buprenorphine & Controlled Substance Treatment Agreement

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

MEDICATION ASSISTED TREATMENT

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Benzodiazepines: Comparative Effectiveness and Strategies for Discontinuation. Ann M. Hamer, PharmD, BCPP Rural Oregon Academic Detailing Project

Medication-Assisted Treatment (MAT) Overview

Discover the Hope: Opiate Treatment and Recovery

Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, PM

Opiate Use Disorder and Opiate Overdose

The CARA & Buprenorphine Prescribing for APNs & PAs

Understanding Medication in Addiction Treatment for Drug Court Participants

H NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher.

9/13/2017. Buprenorphine Treatment (Suboxone) Disclosures. We ve Got a Big Opioid Problem. Selahattin Kurter, MD Spectrum Healthcare

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

MAT in the Corrections Setting

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE

some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment

Recognizing Narcotic Abuse and Addiction and Helping Those With It

PATIENT INTAKE: MEDICAL HISTORY. Name. Address. Phone (W) (H) (C) DOB Age SS# Emergency Contact. Relationship to patient Phone

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)

COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION. Name Birthdate / /

Disclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O.

TELEPHONE SCREENING DEMOGRAPHIC INFO

Treatment Approaches for Drug Addiction

NIDA Quick Screen V1.0F1

Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR

Prescription Opioids

20/0.8mg, 30/1.2mg, Films 90 MME/day Belbuca (buprenorphine) 75mcg, 150mcg, 300mcg, 450mcg 60 units per 90 days

SUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets. Risk Evaluation and Mitigation Strategy (REMS) Program

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Earl Hightower's Remarks 2014 National Rx Drug Abuse Summit Medication Assisted Treatment for Opiate Addiction

NIDA-Modified ASSIST Prescreen V1.0 1

Medication Assisted Treatment. Nicole Gastala, MD

Buprenorphine as a Treatment Option for Opioid Use Disorder

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry

Vivitrol Drug Court and Medication Assisted Treatment

Opioid dependence and buprenorphine treatment

Buprenorphine 2.0: I have my waiver, now what? Dr. Ritu Bhatnagar, M.D., M.P.H. Dr. John Ewing, M.D., FASAM. Disclosures

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Methadone Maintenance 101

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION

THE STATE OF MEDICINE IN ADDICTION RECOVERY

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

2/21/2018. What are Opioids?

Buprenorphine addiction

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine)

AODA RECOVERY. How to support those in recovery, and those not yet ready to commit

Many drugs of abuse are illegal drugs. Possessing, using, buying, or selling these drugs is illegal for people of any age.

Suboxone, Zubsolv, Bunavail (buprenorphine with naloxone sublingual tablets and film), Buprenorphine sublingual tablets

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

Opioid Dependence and Buprenorphine Management

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

Anyone Can Become Addicted. Anyone.

A prisoners guide to buprenorphine

Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement

9/9/2016. Drug Name (select from list of drugs shown) Bunavail Buccal Film (buprenorphinenaloxone) Suboxone Sublingual Film (buprenorphine-naloxone)

Opioid Use and Other Trends

ADDICTIONS NURSING IN Holland and Europe. Education now and in the future

NIDA-Modified ASSIST - Prescreen V1.0*

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine)

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

NURSING FOLLOW-UP: BUPRENORPHINE/NALOXONE BUPRENORPHINE/NALOXONE CLINIC VISITS

Michael O Neil, Pharm.D. Professor and Vice-Chair, Department of Pharmacy Practice Drug Diversion, Substance Abuse, and Pain Management Consultant

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

4/5/2018 MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS OBJECTIVES DEFINITION OF ADDICTION APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H.

ADDICTION OPIOID ADDICTION

What Clergy Need To Know. Deacon Dan Giblin, CRS

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

Medications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC

Powering Efficient Behavioral Health Care Services

Take Home Naloxone elearning Module Script

Basics of Benzodiazepine Use Disorder. DATE: October 3, 2017 PRESENTED BY: Melissa B. Weimer, DO, MCR

1/26/2016. These are my own thoughts! Safe Workplace Safe Workforce Proven benefits of Stay At Work / Return To Work Process (SAW/RTW)

the facts about BUPRENORPHINE for Treatment of Opioid Addiction

Xanax help with opiate withdrawal

VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER

Prescription Drug Abuse

Strategies in Managing Opioid and Benzodiazepine Co-Prescribing

Discrimination & the Opioid Crisis

Conflict of Interest Disclosure

Special Populations health complications of Substance Use Anthony Dekker DO, OMED 2018 San Diego

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine

THEXANAX THREAT 1 THE XANAX THREAT. iaddiction.com

Can klonopin help withdrawal opiates

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital

Basics of Benzodiazepine Use Disorder. DATE: June 12, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

USUAL DOSE OF XANAX. Usual Dose Of Xanax

Transcription:

Treatment of the Addicted or Dependent Patient in the Family Practice Setting Jeanette Ann Moleski, D.O. Diplomate of the American Board of Addiction Medicine Osteopathic Board of Family Medicine

Disclosures Speaker and consultant for Orexo Pharmaceuticals Speaker and consultant for BDSI Pharmaceuticals Speaker for Takeda Pharmaceuticals Speaker for Millennium Labs

Addiction: Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry. Dysfunction in these circuits leads to characteristic biological, psychological, social and spiritual manifestations. This is reflected in an individual pathologically pursuing reward and/or relief by substance use and other behaviors.

Addiction Addiction is characterized by inability to consistently abstain, impairment in behavioral control, craving, diminished recognition of significant problems with one s behaviors and interpersonal relationships, and a dysfunctional emotional response. Like other chronic diseases, addiction often involves cycles of relapse and remission. Without treatment or engagement in recovery activities, addiction is progressive and can result in disability or premature death.

Addiction is characterized by: Inability to consistently Abstain; Impairment in Behavioral control; Craving; or increased hunger for drugs or rewarding experiences; Diminished recognition of significant problems with one s behaviors and interpersonal relationships; and A dysfunctional Emotional response.

Dependence: Dependence develops when the neurons adapt to the repeated drug exposure and only function normally in the presence of the drug. When the drug is withdrawn, several physiologic reactions occur. These can be mild (e.g., for caffeine) or even life threatening (e.g., for alcohol). This is known as the withdrawal syndrome. In the case of heroin, opioids, and benzodiazepines, withdrawal can be very serious and the abuser will use the drug again to avoid the withdrawal syndrome.

What addictions/dependencies do you see in your practice?

What addictions/dependencies do you see in your practice? Caffeine Nicotine (cigarettes, chewing tobacco, e-cigs) Alcohol Benzodiazepines Opioids Heroin Gambling Stimulants Media Food Marijuana

Nicotine Nicotine Anonymous Chantix Nicotine Replacement Behavior modification --reduce one cigarette per day per week --increase time between cigarettes --decrease smoking environments

Alcohol Antabuse Naltrexone 50 mg pills/capsules Vivitrol Injectable Abstinence AA Specialty AA Caduceus Smart Recovery (www.smartrecovery.org) Informal programs Paradise Club in Akron

James and Timothy Partners in long term relationship Consuming about 7 alcoholic drinks/day Neither wanted to stop drinking only reduce amount. Refused AA James Naltrexone 50mg orally daily Timothy Moderate obesity and depression treated with Contrave tapered up to full dose Four months later both consuming less than 2 alcoholic drinks per day and on some days totally abstain from alcohol.

Confirmatory testing Alcohol testing Ethyl Glucuronide detectible up to 80 hours Ethyl Sulfate detectible up to 80 hours POC testing for office, but unable to obtain levels.

Benzodiazepines Almost all Benzodiazepines on the street come from patients who sell their prescriptions. Benzodiazepines are generally used with other drugs such as alcohol, heroin, marijuana, prescription opioids, and heroin. Are used to bring the user down off stimulant effects such as cocaine, LSD, or meth. Are used between highs, when unable to get heroin.

Benzodiazepines Xanax the most popular sedative-hypnotic in terms of widespread use. (Surveillance of Drug Abuse Trends in the State of Ohio) Xanax 0.25 mg sells for $0.50-$1.00 Xanax 0.50 mg sells for $0.50-$3.00 Xanax 1 mg sells for $2.00-$5.00 Xanax 2 mg sells for $3.00- $10.00 Taken orally, snorted, and injected.

Benzodiazepines The use of most sedative, hypnotic, or anxiolytic agents can result in the development of psychological dependence, physical dependence or addiction!! A clinically significant withdrawal syndrome is most apt to occur after discontinuation of daily therapeutic dose (low dose) for at least 4-6 months, or with doses that exceed 2-3 times the upper limit of recommended therapeutic (high dose) for > 2-3 month.

Drug Benzodiazepine Equivalency Approx Equivalent Time to Peak Half-life, Oral Doses, mg Level, hours hours (max) Alprazolam (Xanax) 0.5 1-2 12 Chlordiazepoxide (Librium) 25 1-4 100 Clonazepam (Klonopin) 0.25 1.4 100 Diazepam (Valium) 5 1-2 100 Flurazepam (Dalmane) 15 0.5-2 100 Lorazepam (Ativan) 1 1-4 15 Oxazepam (Serax) 15 1-4 8 Temazepam (Restoril) 10 2-3 11 Triazolam (Halcion) 0.25 1-2 2 References C Heather Ashton, DM, FRCP. BENZODIAZEPINE EQUIVALENCY TABLE. Available at http://www.bcnc.org.uk/equivalence.html. Benzodiazepine Equivalence Chart. Available at http://www.mental-health-today.com/rx/benzo.htm. Benzodiazepine Dose Conversions (oral). Available at http://globalrph.com/benzodiazepine_calc.htm. Benzodiazepine Equivalency/Half-Life/Dose Chart. Available at http://www.bluelight.org/vb/threads/99918-benzodiazepine-equivalency-half-life- Dose-Chart.

Why Are Metabolites Important? Sandra, age 37 with opioid use disorder (Suboxone 8-2 one daily) Severe anxiety, jerky heart beats in throat. Hands shake without Valium 15mg b.i.d. since 2013. Current physician has been reducing her dose. She can t function without it. On disability, but won t be able to finish her associate degree with her severe anxiety, if she is tapered from Valium. Sincere, straight forward, no behaviors that raises suspicion. Urine POC drug screen: +BUP and +BZO

Why Are Metabolites Important? Confirmatory Urine Drug Screen: Drug ng/ml Cutoff ng/ml Alpha-Hydroxyalprazolam Neg 20 7-Amino-Clonazepam Neg 20 Lorazepam Neg 40 Nordiazepam Neg 40 Temazepam Neg 50 Oxazepam Neg 40 Buprenorphine >5,000 10 Norbuprenorphine Neg 20 Dextromethorphan 927 50 Dextrorphan metabolite 347 50

Why Are Metabolites Important? Her POC urine test was positive for benzodiazepines. However, the results from confirmatory testing showed none of the expected metabolites of nordiazepam, temazepam or oxazepam. This result is not consistent with the expected urine toxicology results from a person taking Valium (diazepam.) In my professional opinion, there was tampering of this urine specimen. The results are consistent with the addition of Valium (diazepam) to the urine obtained from a person not taking diazepam. In my professional opinion, there was tampering of this urine specimen.

Benzodiazepines Assess the need for medication. Utilize counseling for coping with anxiety. Consider low dose sublingual Melatonin or Trazodone for sleep disorders. Be aware of addiction potential. Check OARRS Recognize the difficulty of tapering. Recognize the need for slow tapering. Death may result with sudden cessation of large amounts of Benzodiazepines. Be aware of potential for diversion, including family members.

Recreational doses: Dextromethorphan 100-200 mg mild, stimulant effect (likened to MDA/Ecstasy) 200-500 mg more intoxicating effect (like being drunk and stoned. ) 500-1,000mg mild hallucinations and mild dissociate effect (likened to low dose of ketamine) and an overall disturbance in thinking, senses and memory. >1,000mg may produce a fully dissociative effect (likened to a high dose of ketamine.) Recreational abused doses are capable of impairing judgment, memory, language and other mental performances.

Overprescribing In 2010 alone, 254 million prescriptions for opioids were filled in the United States, enough for every adult in America to stay medicated around the clock for a month. Patients on Medicaid are prescribed painkillers at twice the rate of non-medicaid patients, and are at six times the risk of prescription painkiller overdose. http://communities.washingtontimes.com/neighborhood/appalachian-chronicles/2012/jun/9/oxycontin-bath-saltsdrug-appalachia-addicts/#ixzz3ol0i3i8a

Overprescribing Americans (4.6% of world s population) consume 80% of the global opioid supply and 99% of global hydrocodone supply and 66% of world s illegal drugs. There has been at least a 10-fold increase in the medical use of opioid painkillers during the last 20 years.

Ohio Substance Abuse Monitoring Network June 2014-January 2015 Prescription opioids remain highly available throughout all of Ohio, except Cincinnati where street availability is moderate. Availability has decreased in Akron-Canton, Cleveland, and Toledo over past 6 months. Tramadol is becoming more available. Many user s choice of drug has switched to heroin. Prescription opioids generally sell for $1-2 per mg. Most common method of use is snorting, followed by oral consumption.

Ohio Substance Abuse Monitoring Network June 2014-January 2015 A profile of a typical illicit user of prescription opioids did not emerge from the data. Typical user is everybody. Prescription opioids often used with alcohol, benzodiazepines, Cocaine and methamphetamine are used with opioid for the speedball effect.

Ohio Opioid/Heroin Statistics In Ohio, Heroin is often 10 times less expensive than pills. An estimated 80% of heroin addicts in Ohio started their addiction with prescription opioids.

Opioids Must be responsible in prescribing and document well. Recommend checking OARRS on every visit where an Rx is written. POC urine testing at every visit. Confirmation testing at first visit and subsequent visits as needed. Make certain you know for whom you are prescribing. Question, question, question. Always look at risk of addiction Pill counts. Look at alternatives for opioids. Use caution with NSAIDs.

Oxycodone Metabolism and Metabolites

States with the highest rate of fatal overdoses were: 1. West Virginia (35.5 deaths per 100,000) 2. New Mexico (27.3 deaths per 100,000) 3. New Hampshire (26.2 deaths per 100,000) 4. Kentucky (24.7 deaths per 100,000) 5. Ohio (24.6 deaths per 100,000)

Surveillance of Drug Abuse Trends in Ohio for Heroin June 2014-January 2015 The current availability of heroin remains high throughout Ohio; availability has increased in six of the eight regions in past six months. Many participants stated heroin is now easier to obtain than marijuana and cocaine. Heroin is now significantly less expensive than prescription opioids. Some treatment providers in the Akron-Canton area noted a trend in clients using heroin without a progression from pain medication to heroin. Toledo participants reported that heroin dealers are so prevalent that they must deliver a high-quality product to maintain customers.

Surveillance of Drug Abuse Trends in Ohio for Heroin June 2014-January 2015 The danger of using fentanyl-cut heroin is well understood, but most participants expressed seeking it out despite their understanding of possible overdose dangers. (China White) China White is also being cut with Cocaine. Most often noted cutting agents for heroin are caffeine, diphenhydramine, fentanyl, mannitol and quinine. Needles on the street sell for $1-5 each. Heroin costs: 1/10 gram for $20; ½ gram for $40-80; gram for $60-300 depending on quality.

Legal Stuff 1914 Harrison Act and the Prohibition of Addiction Treatment illegal to prescribe opioid for the maintenance or treatment of addiction. Upheld by the U.S. Supreme Court in 1919. Drug Addiction Treatment Act of 2000 (DATA 2000) Allows office based treatment with buprenorphine Qualify physicians (8 hours of training) Limit of 30 patients the first year Limit of 100 patients after the first year Additional DEA number beginning with an X ne

Barriers? They don t need treatment, they just need to stop using. It s too much work/paperwork. If they use heroin, they must be bad people. It will upset my staff. They don t deserve my care. They are someone else s child, sister, brother, mother, father, grandchild, aunt, uncle, cousin, friend.....

Forebrain Midbrain Why Can t They Just Stop? Why Do They Relapse? Dopamine Receptors Permanent changes in the brain Heroin dependence: a chronic relapsing brain disease.

Definition Opioid Dependence: A chronic, relapsing, brain disease.

What Are Our Goals? Keep them alive! Keep them out of jail!

Rapid Detox and Taper 7 day taper 12% opioid free at 3 months(lang et al. 2009) 28 day taper 13% opioid free at 3 months(lang et al. 2009) Buprenorphine treatment 60% remain in treatment at 6 months (2006 statistics)

Medicated Assisted Treatment (MAT) Buprenorphine/Naloxone Suboxone 8mg/2mg Sublingual Films Zubsolv 5.7mg/1.4mg Sublingual Tablets Bunavail 4.2mg/0.7mg Buccal Films Buprenorphine Subutex 8mg Sublingual Tablets (generic) Naloxone Vivitrol naltrexone for extended-release injectable suspension Methadone

Where to Begin? Identify and understand the problem. It is a chronic, relapsing, brain disease. It is not a character flaw. We have to have the desire and compassion to help.

Where to Begin? American Osteopathic Academy of Addiction Medicine Telephone: (708) 338-0760 pcssb@aoaam.org PCSS-O is a national training and mentoring project developed in response to the prescription opioid overdose epidemic. Free. Mentoring program. pcss-o.org American Society of Addiction Medicine www.asam.org http://buprenorphine.samhsa.gov (excellent resources) Handbook of Office-Based Buprenorphine Treatment of Opioid Dependence by John A Renner Jr., M.D. and Petros Levounis, M.D., M.A.

Where to Begin? Step 1: Order your textbook Handbook of Office-Based Buprenorphine Treatment of Opioid Dependence by John A Renner Jr., M.D. and Petros Levounis, M.D., M.A. Step 2: Complete your 4 hour training at home and arrange for your 4 hour face-to-face training. Step 3: American Osteopathic Acedemy of Addiction Medicine will help you apply for new X DEA Number.

Where to Begin? Step 4: Forms for your buprenorphine charts.http://www.csam-asam.org/buprenorphine-info Step 5: Method to keep track of number of patients Step 6: Register for physician locator: http://buprenorphine.samhsa.gov/bwns_locator) Step 7: Have a written protocol. (e-mail me drjamoleski@yahoo.com ) Step 8: Determine how you will screen patients.

Where to Begin? Step 9: Determine your payment and fees. Step 10: Get your CLIA waved office drug urine/saliva tests Step 11: Find a lab for confirmations and metabolites. Step 12: Find counselors for referrals. Step 13: Schedule your first patient and allow a little extra time. Step 14: Call me if you have any questions

Rule 4731-11-12 Office Based Opioid Treatment Passed 01/16/2015 Effective 01/31/2015 Non-Addiction Medicine Boarded Physicians are limited to prescribing buprenorphine 16mg or less per day. Mandated behavior health treatment. Mandatory testing for Hepatitis B, Hepatitis C, pregnancy, alcohol and toxicology testing. OARRS review at least every 90 days. Patient is limited to no more than a 30 day supply during the first 12 months.

Rule 4731-11-12 Office Based Opioid Treatment Eight hours of Category 1 continuing education relating to substance abuse and addiction every two years. Practice in accordance with an acceptable treatment protocol any of the following: 1. Clinical Guidelines For the Use of Buprenorphine in the Treatment of Opioid Addiction. (http://samhsa.gov/) 2. Low dose protocol approved by the Ohio Department of Alcohol and Drug Addiction Services (http://mha.ohio.gov/) 3. Any protocol for OBOT approved by the Ohio Department of Mental Health and Addiction Services (http://mha.ohio.gov.)

Rewards Save lives Save families Reduce prison population Satisfaction of helping patients who want help Protect future generation Financial Gratitude of your patients, their families, and their friends